Pharmacokinetic study of zandopa® in rat model
By: Kolge, S
.
Contributor(s): Dhande, Swati.
Publisher: Mumbai Indian Journal of Pharmaceutical Science 2023Edition: Vol.85(4), Jul-Aug.Description: 1163-1168p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Indian journal of pharmaceutical sciencesSummary: The goal of this research is to examine the pharmacokinetics of Zandopa® in rats after oral administration of
Zandopa® herbal formulation. Acclimatization of rats was done for 7 d before the study. The study consisted
of 24 rats which had been separated equally into two groups i.e. vehicle control and Zandopa® control group
with 12 animals in each group. The drug was administered via oral route in male Sprague Dawley rats.
The vehicle control group rats were dosed with 1 % carboxymethyl cellulose and Zandopa® control group
with 775 mg/kg of Zandopa® in 1 % carboxymethyl cellulose. Food was with-held for a further 1 h. The
blood sample was taken between 0, 0.5, 1, 2, 4, 6, 8, 12 and 24 h time intervals after treatment with the
respective drug. Plasma samples were prepared by centrifugation and concentration was measured by high
performance liquid chromatography. Urine was collected at a time interval of 0-1, 1-4, 4-8, 8-24, 24-48 h after
treatment with the respective drug, and kinetic parameters were measured. Then animals were sacrificed
using isoflurane overdose and the liver was isolated and stored for metabolism study. The Cytochrome P-450
concentration and Cytochrome P-450 content was found to be 0.0012 mM and 1.2 nmol/mg/protein compared
with the vehicle control group. The cumulative amount excreted was found to be 64.66 mg. The study of the
pharmacokinetics of Zandopa® in rats was shown to be significant as compared to the vehicle control group.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2024-0428 |
The goal of this research is to examine the pharmacokinetics of Zandopa® in rats after oral administration of
Zandopa® herbal formulation. Acclimatization of rats was done for 7 d before the study. The study consisted
of 24 rats which had been separated equally into two groups i.e. vehicle control and Zandopa® control group
with 12 animals in each group. The drug was administered via oral route in male Sprague Dawley rats.
The vehicle control group rats were dosed with 1 % carboxymethyl cellulose and Zandopa® control group
with 775 mg/kg of Zandopa® in 1 % carboxymethyl cellulose. Food was with-held for a further 1 h. The
blood sample was taken between 0, 0.5, 1, 2, 4, 6, 8, 12 and 24 h time intervals after treatment with the
respective drug. Plasma samples were prepared by centrifugation and concentration was measured by high
performance liquid chromatography. Urine was collected at a time interval of 0-1, 1-4, 4-8, 8-24, 24-48 h after
treatment with the respective drug, and kinetic parameters were measured. Then animals were sacrificed
using isoflurane overdose and the liver was isolated and stored for metabolism study. The Cytochrome P-450
concentration and Cytochrome P-450 content was found to be 0.0012 mM and 1.2 nmol/mg/protein compared
with the vehicle control group. The cumulative amount excreted was found to be 64.66 mg. The study of the
pharmacokinetics of Zandopa® in rats was shown to be significant as compared to the vehicle control group.
Click on an image to view it in the image viewer
There are no comments for this item.